Tickers

EML — Ticker Eval done nvidia/nemotron-3-ultra-550b-a55b:free

Requested 2026-09-22 11:41:43.663206 UTC · finished 2026-09-22 11:47:20.370295 UTC

1. Composite Trajectory Verdict

All three statements carry roughly equal weight for this capital-intensive industrial manufacturer with significant working capital needs, pension obligations, and recent acquisition activity.

Composite Trajectory: Mixed

The annual income statement shows clear deterioration (revenue -8.7%, operating margin -310 bps, net income -55% FY2025 vs FY2024). The Q2 2026 quarterly results show similar operating deterioration (revenue -12%, operating margin -180 bps), though GAAP net income rose due to a $6.5M bargain purchase gain from the Sinecera/Sungear acquisition. Adjusted (non-GAAP) net income fell 74% in Q2 and 72% YTD. Annual operating cash flow declined 54% YoY, while YTD 2026 operating cash flow improved to $12.0M from $1.9M, driven by a $9.0M accounts payable increase (timing). The balance sheet improved FY2025 vs FY2024 (debt/equity 27% vs 35%, current ratio 3.7 vs 2.6) but deteriorated in Q2 2026 vs FY2025 (debt/equity 32% vs 27%, current ratio 2.8 vs 3.7) post-acquisition.

2. Red Flags

  • GAAP net income up in Q2/YTD 2026 solely due to $6.5M bargain purchase gain; adjusted net income down 74%/72% (10-Q 2026-07-04, Reconciliation of Non-GAAP Measures)
  • Gross margin compression accelerating: FY -180 bps, Q2 -270 bps, YTD -280 bps YoY (10-K 2026-01-03, MD&A; 10-Q 2026-07-04, Results of Operations)
  • Revenue decline broadening: FY -8.7%, Q2 -12%, YTD -11% YoY across truck mirrors, returnable packaging, latches/handles (10-K 2026-01-03, MD&A; 10-Q 2026-07-04, MD&A)
  • Working capital deterioration masked by payables timing: YTD accounts payable +$9.0M vs +$2.5M prior year, inventory +17% vs sales -11% (10-Q 2026-07-04, Liquidity; Consolidated Balance Sheets)
  • Leverage increased post-acquisition: total debt $41.7M vs $33.9M, debt/equity 32.1% vs 27.2% (10-Q 2026-07-04, Consolidated Balance Sheets; 10-K 2026-01-03, Consolidated Balance Sheets)
  • Tariff costs rising: $5.0M YTD 2026 vs $3.0M YTD 2025 on China-sourced products (10-Q 2026-07-04, MD&A)
  • Pension underfunding persistent: $14.4M net liability (10-K 2026-01-03, Note 10)

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Deteriorating

Revenue has declined in three consecutive comparable periods: FY2025 -8.7% to $249.0M (10-K 2026-01-03), Q2 2026 -12% to $61.8M, YTD 2026 -11% to $121.5M (10-Q 2026-07-04). Gross margin compressed each period: FY 22.9% vs 24.7%, Q2 20.6% vs 23.3%, YTD 20.3% vs 23.1%. Operating profit fell FY -47% to $10.7M, Q2 -47% to $1.7M, YTD -56% to $3.0M. GAAP net income from continuing operations fell FY -55% to $6.0M; Q2/YTD GAAP increases ($5.6M/$6.3M vs $2.0M/$4.2M) are entirely attributable to a $6.5M bargain purchase gain. Adjusted (non-GAAP) net income fell Q2 -74% to $0.9M, YTD -72% to $1.6M.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Annual operating cash flow declined 54% to $8.9M in FY2025 from $19.4M in FY2024 (10-K 2026-01-03, Consolidated Statements of Cash Flows), with working capital consuming $5.4M vs providing $4.9M prior year. YTD 2026 operating cash flow improved to $12.0M from $1.9M YTD 2025 (10-Q 2026-07-04, Consolidated Statements of Cash Flows), but this was driven by a $9.0M accounts payable increase (vs $2.5M prior year) and exclusion of the $6.5M non-cash bargain purchase gain. Free cash flow (operating less capex) was $4.9M in FY2025 ($8.9M - $4.0M capex) vs $9.7M in FY2024. Investing cash flow shifted to -$9.5M YTD 2026 (including $8.0M acquisition) from +$1.8M YTD 2025. Financing cash flow was +$5.2M YTD 2026 (debt issuance) vs -$9.8M YTD 2025.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

FY2025 vs FY2024 showed improvement: debt/equity 27% vs 35%, current ratio 3.7 vs 2.6, working capital $71.7M vs $68.4M, cash $7.4M vs $14.0M (10-K 2026-01-03). Q2 2026 vs FY2025 shows post-acquisition deterioration: debt/equity 32.1% vs 27.2%, current ratio 2.8 vs 3.7, total debt $41.7M vs $33.9M, but cash increased to $15.1M from $7.4M (10-Q 2026-07-04). Inventory rose 17% to $66.0M vs $56.3M while YTD sales fell 11%; receivables rose 22% to $36.8M vs $30.1M. Goodwill increased slightly to $58.7M from $58.6M; intangibles fell to $4.1M from $5.3M due to amortization. Pension liability improved to $13.1M from $14.4M.

6. Data Gaps

  • Quarterly cash flow statements for standalone Q2 2026 vs Q2 2025 (only YTD provided in 10-Q 2026-07-04)
  • Q1 2026 vs Q1 2025 income statement and cash flow details (10-Q 2026-04-04 XBRL truncated)
  • Q3 2025 vs Q3 2024 comparable quarterly data (10-Q 2025-09-27 XBRL truncated)
  • Q2 2025 vs Q2 2024 comparable quarterly data (10-Q 2025-06-28 XBRL truncated)
  • Segment-level revenue breakdown by product line for quarterly periods
  • Capital expenditure forecast for FY2026 beyond "approximately $7.3 million" (10-K 2026-01-03)
  • Detailed tariff refund claims status and potential magnitude (10-Q 2026-07-04 mentions process but no amounts recorded)
  • Integration costs and synergy targets for Sinecera/Sungear acquisition (10-Q 2026-07-04 mentions $1.7M aerospace/defense sales but no cost details)
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status